Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-09
2005-08-09
Low, Christopher S. F. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C367S086000, C367S086000, C367S086000, C367S086000, C367S086000, C367S086000
Reexamination Certificate
active
06927223
ABSTRACT:
The invention provides a method for the treatment of cancer comprising administering a serotonin agent. Also provided is a method for the treatment of cachexia comprising administering a serotonin agent.
REFERENCES:
patent: 3561444 (1971-02-01), Boucher
patent: 3703173 (1972-11-01), Dixon
patent: 4051842 (1977-10-01), Hazel et al.
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4383529 (1983-05-01), Webster
patent: 4624251 (1986-11-01), Miller
patent: 4635627 (1987-01-01), Gam
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5560922 (1996-10-01), Chlen et al.
patent: 5859065 (1999-01-01), Brandes
patent: 5879712 (1999-03-01), Bomberger et al.
patent: WO-94/07529 (1994-04-01), None
Abdul et al., Journal of Urology, vol. 154, pp 247-250, Jul., 1995.
Carter et al., Chemotherapy of Cancer, Second Edition, 1981, John Wiley & Sons, N.Y., N.Y., pp 362-365.
Abdul, M.,et al., “Growth-Inhibitory Effects of Serotonin uptake Inhibitors on Human Prostate Carcinoma Cell Lines”,The Journal of Urology, 154, (1995), pp. 247-250.
Brandes, L.J., et al., “Stimulation of Malignant Growth in Rodents by Antidepressant Drugs at Clinically Relevant Doses,”Cancer Research, 52, (1992), pp. 3496-3800.
Iken, K.et al., “Serotonin Upregulates Mitogen-Stimuilated B Lymphocyte Proliferation through 5-HT1A Receptors”,Cellular Immunology, 163, (1995), pp. 1-9.
Joki, T., et al., “Continuous release of endostatin from microencapsulated engineered cells for tumor therapy”,Nature Biotechnology, 19, (Jan. 2001), pp. 35-39.
Liu, Y., et al., “Haloperidol and Spiperone potentiate murine splenic B cell proliferation”,Immunopharmacology, 34, (1996), pp. 147-159.
Merzak, A., et al., “Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration”,Molecular Brain Research, 41, (1996), pp. 1-7.
Newman, S.P., “Chapter 9: Therapeutic aerosols”,In: Aerosols and the Lung: Clinical and Experimental Aspects, Stewart W. Clarks, et al., Eds. Butterworth (Publisher), (1984), pp. 197-224.
Pakala, R., et al., “Effect of Serotonin, Thromboxane A2, and Specific Receptor Antagonists on Vascular Smooth Muscle Cell Proliferation”,Circulation, 96(7), (1997), pp. 2280-2286.
Sheehan, P.F.J.,et al., “Effects of Histamine and 5-Hydroxytryptamine on the Growth Rate of Xenografted Human Bronchogenic Carcinomas”,Clinical and Experimental Pharmacology and Physiology, 23, (1998), pp. 465-471.
Steingart, A.B., et al., “Do Antidepressants Cause, Promote, or Inhibit Cancers”, J. Clin. Epidemiol., 48( 11), (1995), pp. 1407-1412.
Uehara, Y. et al., “Antiproliferative Effects of the Serotonin Type 2 Receptor Antagonist, Ketanserin, on Smooth Muscle Cell Growth in Rats”,Journal of Cardiovascular Pharmacology, 17 (Suppl. 2), (1991), pp. S154-S156.
Westphal, R.S.,et al., “Differences in Agonist-Independent and -Dependent 5-Hydroxytryptamine2C Receptor-Mediated Cell Division”,Molecular Pharmacology, 49, (1996), pp. 474-480.
Young, M.R.I., et al., “Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin”,Immunology, 80, (1993), pp. 395-400.
Zachrisson, K.,et al., “Serotonin and neuroendocrine peptides influence DNA synthesis in rat and human small intestinal cells in vitro”,Acta Physiol. Scand.163, (1998), pp. 195-200.
Meadows Gary G.
Obradovic Tanja
Lewis Amy
Low Christopher S. F.
Schwegman Lundberg Woessner & Kluth P.A.
Washington State University Research Foundation
LandOfFree
Use of serotonin agents for adjunct therapy in the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of serotonin agents for adjunct therapy in the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of serotonin agents for adjunct therapy in the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3511594